Studies > 1000 Participants

Community Health Applied Research Network (CHARN)

  • Principal Investigator(s): Kenneth Mayer, MD
  • Study Contact: Kenneth Mayer, MD
  • Description of Subjects: Patients receiving primary care at participating community health centers across the U.S.
  • Location (Domestic vs. International): Boston, MA; greater MA; New England
  • Enrollment Period: 2007-2014
  • Enrollment Goal: >50,000

Optimizing PrEP through Shared Decision Making

  • Principal Investigator(s): Douglas Krakower
  • Study Contact: Douglas Krakower
  • Description of Subjects: HIV-uninfected men who have sex with men
  • Location (Domestic vs. International): BIDMC, Fenway Health, Greater Boston region (i.e., from community)
  • Enrollment Period: 2013 to present
  • Enrollment Goal: 100 participants

The MATCH Study of HIV and Aging

  • Principal Investigator(s): Monty Montano
  • Study Contact: Brooke Ferguson Brawley; BBRAWLEY@PARTNERS.ORG617-525-9195
  • Description of Subjects: Adult males and females, 50-65 years old. If HIV+, on effective ART.
  • Location (Domestic vs. International): Boston Metropolitan Area
  • Enrollment Period: 2015-2016
  • Enrollment Goal: 200

Kaposi's sarcoma treatment in Kenya and Nigeria

  • Principal Investigator(s): Esther Freeman
  • Study Contact: efreeman@mgh.harvard.edu
  • Description of Subjects: Adults with HIV-related Kaposi's sarcoma in Kenya and Nigeria
  • Location (Domestic vs. International): AMPATH (Eldoret, Kenya), Institute of Human Virology (Abuja, Nigeria)
  • Enrollment Period: 2009-2012
  • Enrollment Goal: All KS patients diagnosed at these sites during enrollment period

Cotrimoxazole safety study

  • Principal Investigator(s): Scott Dryden-Peterson
  • Study Contact: Scott Dryden-Peterson, +2.677.447.2522, scott_peterson@post.harvard.edu
  • Description of Subjects: Infants born to HIV-infected women
  • Location (Domestic vs. International): Botswana
  • Enrollment Period: 2008-2009
  • Enrollment Goal: 444 mother-infant pairs

Botswana Prospective Cancer Cohort

  • Principal Investigator(s): Scott Dryden-Peterson
  • Study Contact: Scott Dryden-Peterson, +2.677.447.2522, scott_peterson@post.harvard.edu
  • Description of Subjects: Botswana adults with a new diagnosis of cancer
  • Location (Domestic vs. International): Botswana Harvard AIDS Institute
  • Enrollment Period: 2010-ongoing
  • Enrollment Goal: 3000

HIV Research Network (HIVRN)

  • Principal Investigator(s): Stephen Boswell, MD
  • Study Contact: Sarah Wolfrum, DrPH, 617-927-6367, swolfrum@fenwayhealth.org
  • Description of Subjects: HIV-infected patients aged 18 and older receiving medical care at Fenway Health. (HIVRN includes pediatric data, but Fenway Health only submits adult patient data)
    • HIV+
    • HIV/HCV Co-infected

Uganda AIDS Rural Treatment Outcomes Cohort Study

  • Principal Investigator(s): David Bangsberg, MD
  • Study Contact: Rachel Rifkin617.724.3194rrifkin@partners.org
  • Description of Subjects: All patients over 18 years and initiating ART at the Mbarara Immune Suppression Syndrome Clinic who lived within 60 kilometers from the clinic
  • Location (Domestic vs. International): Mbarara, Uganda

Pages